Inventor
Donald F. Hunt
Inventor
Charlottesville, VA, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides20%
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
H01JElectric discharge tubes or discharge lamps15%
Y10TTechnical subjects covered by former us classification7%
C12NMicroorganisms or enzymes3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C12YEnzymes1%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data1%
PatentTitleYear
10,682,399Target peptides for colorectal cancer therapy and diagnostics202010,640,535Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies202010,281,473Compositions and methods for analysis of protein sequences and post-translational modifications20199,561,266'Target peptides for immunotherapy and diagnostics'20179,279,011'Phosphopeptides as melanoma vaccines'20169,171,707'Reagents for electron transfer dissociation in mass spectrometry analysis'20158,758,767'Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof'20148,692,187'Electron transfer dissociation for biopolymer sequence analysis'20148,211,436'Anticancer vaccine and diagnostic methods and reagents'20128,119,984'Method and apparatus for generation of reagent ions in a mass spectrometer'20127,749,769'Simultaneous sequence analysis of amino- and carboxy-termini'20107,704,507'Anticancer vaccine and diagnostic methods and reagents'20107,534,622'Electron transfer dissociation for biopolymer sequence mass spectrometric analysis'20097,205,119'HA-1 antigen'20077,026,167'Systems and methods for the analysis of protein phosphorylation'20067,019,112'Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor'20067,008,922'H-Y antigen'20066,878,375'HA-1 antigen'20056,660,276'Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor'20036,558,671'Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses therefor'20036,521,598'H-Y antigen'20036,315,905'Method for structural characterization of biological moieties through HPLC separation'20016,139,734'Apparatus for structural characterization of biological moieties through HPLC separation'20005,770,201'HA-2 antigenic peptide'19984,175,234'Apparatus for producing ions of thermally labile or nonvolatile solids'19794,156,814'Apparatus for producing ions of thermally labile or nonvolatile solids'19794,136,280'Positive and negative ion recording system for mass spectrometer'19794,066,894'Positive and negative ion recording system for mass spectrometer'1978Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1978–2010Patents assigned to UNIV VIRGINIA (11)· patent assignee history
1978–2020Based in Charlottesville, VA, US· patent location history
2003–2007Patents assigned to UNIV LEIDEN (4)· patent assignee history
2012–2019Patents assigned to HUNT DONALD F (7)· patent assignee history
2012–2016Patents assigned to Univ Virginia Patent Found (6)· patent assignee history
2012–2016Patents assigned to SHABANOWITZ JEFFREY (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV VIRGINIA | 11 | 1978–2010 |
| HUNT DONALD Fself | 7 | 2012–2019 |
| Univ Virginia Patent Found | 6 | 2012–2016 |
| UNIV LEIDEN | 4 | 2003–2007 |
| SHABANOWITZ JEFFREY | 3 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Charlottesville, Virginia, US | 28 | 1978–2020 |